This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 112/7/1047    most recent CIRCULATIONAHA.104.531251v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chu, Y. Articles by Heistad, D. D. Search for Related Content PubMed PubMed Citation Articles by Chu, Y. Articles by Heistad, D. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE GLYCINE Related Collections Gene therapy Oxidant stress Endothelium/vascular type/nitric oxide Animal models of human disease Cell biology/structural biology Functional genomics Hypertension - basic studies

(Circulation. 2005;112:1047-1053.)
© 2005 American Heart Association, Inc.

Vascular Medicine

Vascular Effects of the Human Extracellular Superoxide Dismutase R213G Variant

Yi Chu, PhD; Abdullah Alwahdani, MD; Shinichiro Iida, MD, PhD; Donald D. Lund, PhD; Frank M. Faraci, PhD; Donald D. Heistad, MD

From the Cardiovascular Center and Departments of Internal Medicine (Y.C., A.A., S.I., D.D.L., F.M.F., D.D.H.) and Pharmacology (F.M.F., D.D.H.), University of Iowa, Roy J. and Lucille A. Carver College of Medicine, and VA Medical Center (D.D.L., D.D.H.), Iowa City, Iowa.

Correspondence to Dr Donald D. Heistad, Department of Internal Medicine, University of Iowa, Roy J and Lucille A. Carver College of Medicine, Iowa City, IA 52242. E-mail donald-heistad{at}uiowa.edu

Received December 21, 2004; revision received April 29, 2005; accepted May 6, 2005.

Background— Extracellular superoxide dismutase (ECSOD) is a major extracellular antioxidant enzyme. We have demonstrated that vascular effects of ECSOD require an intact heparin-binding domain. A common genetic variant with a substitution in the heparin-binding domain (ECSOD_R213G) was reported recently to be associated with ischemic heart disease. The goal of this study was to examine vascular effects of ECSOD_R213G.

Methods and Results— A recombinant adenovirus (Ad) that expresses ECSOD_R213G was constructed. ECSOD_R213G and ECSOD proteins bound to collagen type I in vitro, but binding to aorta ex vivo was 10-fold greater with ECSOD than ECSOD_R213G. Three days after intravenous injection of AdECSOD_R213G or AdECSOD in spontaneously hypertensive rats (SHR), immunostaining demonstrated binding of ECSOD to carotid arteries and kidneys but minimal binding of ECSOD_R213G. Binding to aorta and carotid artery was 2.5- to 3-fold greater with ECSOD than ECSOD_R213G by immunoblotting. Arterial pressure was significantly reduced by AdECSOD but not by AdECSOD_R213G. Responses to acetylcholine and basal levels of nitric oxide in carotid arteries were impaired in SHR compared with normotensive Wistar-Kyoto rats and were improved after AdECSOD but not AdECSOD_R213G. Levels of superoxide and nitrotyrosine in aorta were higher in SHR than Wistar-Kyoto rats and were greatly reduced after AdECSOD but not AdECSOD_R213G.

Conclusions— In contrast to ECSOD, ECSOD_R213G has no significant protective effect on arterial pressure, vascular function, or vascular levels of oxidative stress in SHR. These findings may provide a mechanistic basis for association studies that suggest that human beings carrying ECSOD_R213G are predisposed to vascular diseases.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				L. Ai, M. Rouhanizadeh, J. C. Wu, W. Takabe, H. Yu, M. Alavi, R. Li, Y. Chu, J. Miller, D. D. Heistad, et al. Shear stress influences spatial variations in vascular Mn-SOD expression: implication for LDL nitration Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1576 - C1585. [Abstract] [Full Text] [PDF]

				A.-L. Levonen, E. Vahakangas, J. K. Koponen, and S. Yla-Herttuala Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives Circulation, April 22, 2008; 117(16): 2142 - 2150. [Abstract] [Full Text] [PDF]

				M. C. Gongora and D. G. Harrison Sad Heart From No SOD Hypertension, January 1, 2008; 51(1): 28 - 30. [Full Text] [PDF]

				D. D. Lund, Y. Chu, R. M. Brooks, F. M. Faraci, and D. D. Heistad Effects of a common human gene variant of extracellular superoxide dismutase on endothelial function after endotoxin in mice J. Physiol., October 15, 2007; 584(2): 583 - 590. [Abstract] [Full Text] [PDF]

				W. J. Welch, T. Chabrashvili, G. Solis, Y. Chen, P. S. Gill, S. Aslam, X. Wang, H. Ji, K. Sandberg, P. Jose, et al. Role of Extracellular Superoxide Dismutase in the Mouse Angiotensin Slow Pressor Response Hypertension, November 1, 2006; 48(5): 934 - 941. [Abstract] [Full Text] [PDF]

				Y. Chu, R. Piper, S. Richardson, Y. Watanabe, P. Patel, and D. D. Heistad Endocytosis of Extracellular Superoxide Dismutase Into Endothelial Cells: Role of the Heparin-Binding Domain Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1985 - 1990. [Abstract] [Full Text] [PDF]

				S. Iida, Y. Chu, R. M. Weiss, Y. M. Kang, F. M. Faraci, and D. D. Heistad Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H914 - H920. [Abstract] [Full Text] [PDF]

				D. D. Heistad Oxidative Stress and Vascular Disease: 2005 Duff Lecture Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 689 - 695. [Abstract] [Full Text] [PDF]